CureTech Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Liquidation

  • Financing Rounds
  • 9

CureTech General Information

Description

Developer of immune modulating products for the treatment and control of cancer. The company's immune modulating products offer antibodies and peptide-based vaccines to modulate anti-cancer activities, attenuate tumor growth and eliminate tumor metastases in a variety of model systems and exhibits anti-cancer immune response against tumors and pediatric brain cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 42 Hayarkon Street
  • Yavne 81227
  • Israel
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 42 Hayarkon Street
  • Yavne 81227
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CureTech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CureTech‘s full profile, request access.

Request a free trial

CureTech Patents

CureTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9580504-B1 Pidilizumab monoclonal antibody therapy following stem cell transplantation Inactive 07-Nov-2013
ES-2664622-T3 Humanized immunomodulatory monoclonal antibody variants Active 24-Jul-2011
AU-2012288413-A1 Variants of humanized immunomodulatory monoclonal antibodies Active 24-Jul-2011
AU-2012288413-B2 Variants of humanized immunomodulatory monoclonal antibodies Inactive 24-Jul-2011
CA-2840018-A1 Variants of humanized immunomodulatory monoclonal antibodies Active 24-Jul-2011 C07K16/18
To view CureTech’s complete patent history, request access »

CureTech FAQs

  • When was CureTech founded?

    CureTech was founded in 2001.

  • Where is CureTech headquartered?

    CureTech is headquartered in Yavne, Israel.

  • What industry is CureTech in?

    CureTech’s primary industry is Biotechnology.

  • Is CureTech a private or public company?

    CureTech is a Private company.

  • What is CureTech’s current revenue?

    The current revenue for CureTech is .

  • How much funding has CureTech raised over time?

    CureTech has raised $4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process